87 related articles for article (PubMed ID: 6199456)
1. Isolation and biological characterization of mouse LM fibroblast variants resistant to the cytotoxicity of polyriboinosinic polyribocytidylic acid after interferon treatment.
Faure T; Milhaud PG; Fruteau de Laclos H; Mechti N; Silhol M; Huez G; Lebleu B
J Gen Virol; 1984 Mar; 65 ( Pt 3)():617-27. PubMed ID: 6199456
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the production of bovine type I interferon on bovine embryonic lung cells by polyriboinosinic-polyribocytidylic acid.
Rossi CR; Kiesel GK
Am J Vet Res; 1980 Apr; 41(4):557-60. PubMed ID: 6157341
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
Emeny JM; Morgan MJ
J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
[TBL] [Abstract][Full Text] [Related]
4. Interferon production by human-mouse hybrid cells: dominant mouse control of superinduction and priming.
Graves HE; Meager A
J Gen Virol; 1980 Apr; 47(2):489-95. PubMed ID: 6154131
[TBL] [Abstract][Full Text] [Related]
5. Molecular species of interferon induced in mouse L cells by Newcastle disease virus and polyriboinosinic-polyribocytidylic acid.
Erickson JS; Paucker K
J Gen Virol; 1979 Jun; 43(3):521-9. PubMed ID: 479847
[TBL] [Abstract][Full Text] [Related]
6. Purification and initial characterization of human placental trophoblast interferon induced by polyriboinosinic.polyribocytidylic acid.
Aboagye-Mathiesen G; Tóth FD; Juhl C; Nørskov-Lauritsen N; Petersen PM; Ebbesen P
J Gen Virol; 1990 Dec; 71 ( Pt 12)():3061-6. PubMed ID: 1703216
[TBL] [Abstract][Full Text] [Related]
7. Essentially pure murine interferon-alpha/beta primes poly rI:rC and Sendai virus-induced interferon production in mice.
Rosztóczy I; Megyeri K
J Biol Regul Homeost Agents; 1989; 3(1):35-8. PubMed ID: 2472043
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
Stewart WE; De Clercq E; Billiau A; Desmyter J; De Somer P
Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
[TBL] [Abstract][Full Text] [Related]
9. Requirement for endocytosis of poly(rI).poly(rC) to generate toxicity on interferon-treated LM cells.
Milhaud PG; Silhol M; Salehzada T; Lebleu B
J Gen Virol; 1987 Apr; 68 ( Pt 4)():1125-34. PubMed ID: 2437242
[TBL] [Abstract][Full Text] [Related]
10. Responses to interferon of LM cells growing continuously in the absence of serum and exogenous lipids.
Milhaud PG; Faure T; Chaintreuil J; Cathala JM; Lebleu B
J Gen Virol; 1983 Feb; 64 (Pt 2)():485-9. PubMed ID: 6187895
[TBL] [Abstract][Full Text] [Related]
11. The toxic effect of double-stranded RNA for interferon-treated cells: evidence for a heterogeneous cellular response and the role of the cell nucleus.
Cooper JA; Morser J; Colby MS; Burke DC
J Gen Virol; 1979 Jun; 43(3):553-61. PubMed ID: 479849
[TBL] [Abstract][Full Text] [Related]
12. Induction and cross-species activity of rat fibroblast-derived interferon.
Abreu SL; Cannella MS; Hanke J
Microbios; 1981; 30(121-122):181-90. PubMed ID: 6171704
[TBL] [Abstract][Full Text] [Related]
13. Study of the priming effect of interferon in L cells. I. The primed interferon response and the kinetics of development of priming.
Rosztóczy I
Acta Virol; 1976 Dec; 20(6):472-8. PubMed ID: 13642
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein kinase C inhibitors on interferon-beta production by viral and non-viral inducers.
Thacore HR; Lin HY; Davis PJ; Schoenl M
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2833-9. PubMed ID: 2177082
[TBL] [Abstract][Full Text] [Related]
15. Interferon production linked to toxicity of polyriboinosinic acid-polyribocytidylic acid.
De Clercq E; Stewart WE; De Somer P
Infect Immun; 1972 Sep; 6(3):344-7. PubMed ID: 4564891
[TBL] [Abstract][Full Text] [Related]
16. Binding of polyriboinosinic-polyribocytidylic acid with cultured cells.
Kohno S; Shirasawa N; Umino Y; Matsuno T; Kohase M
Arch Virol; 1975; 49(2-3):229-37. PubMed ID: 1239991
[TBL] [Abstract][Full Text] [Related]
17. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.
Levy HB; Baer G; Baron S; Buckler CE; Gibbs CJ; Iadarola MJ; London WT; Rice J
J Infect Dis; 1975 Oct; 132(4):434-9. PubMed ID: 810520
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
19. Priming increases the amount of interferon mRNA in poly(rI).poly(rC)-treated L cells.
Fujita T; Saito S; Kohno S
J Gen Virol; 1979 Nov; 45(2):301-8. PubMed ID: 94345
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of interferon production by poly(rI)-poly(rC) in mouse cell cultures by ascorbic acid.
Siegel BV
Nature; 1975 Apr; 254(5500):531-2. PubMed ID: 1121329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
